David Malka

机构：Institute Mutualiste Montsouris · ORCID：0000-0002-7664-0130

发表论文 449 篇 · 总被引 21013 次 · h-index 72

代表论文

• Cholangiocarcinoma 2026: status quo, unmet needs and priorities (2025 · Nature Reviews Gastroenterology & Hepatology · 被引 71)
• Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT) (2024 · European Journal of Cancer · 被引 29)
• New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe (2025 · The Lancet Regional Health - Europe · 被引 27)
• Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver ( AFEF ) (2024 · Liver International · 被引 19)
• Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, phase III umbrella trial (SAFIR-ABC10—Precision Medicine) (2025 · ESMO Open · 被引 15)
• Pancreatic adenocarcinoma third line systemic treatments: a retrospective cohort study (2024 · BMC Cancer · 被引 14)